Patents expiring in 2037

US 9801872

Pyridinyl and fused pyridinyl triazolone derivatives

Takeda Pharmaceutical Company Limited · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9801938

Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists

FREISTAAT BAYERN REPRESENTED BY JULIUS-MAXIMILLIANS-UNIVERSITÄT WÜRZBURG · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9801884

Nucleotide analogs

The Regents of the University of California · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9801945

Long-acting polymeric delivery systems

Heron Therapeutics, Inc. · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9801873

Methods for treating humans having brain cancer

Nektar Therapeutics · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9802942

Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity

Northwestern University · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9801864

Methods of increasing tonic inhibition and treating secondary insomnia

OVID THERAPEUTICS INC. · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9801863

Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis

The Board of Regents of the University of Texas System · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2017312342

Long-Acting Growth Hormone Dosage Forms

ASCENDIS PHARMA ENDOCRINOLOGY DIV AS [DK] · Granted Thu Nov 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3022447

COMPOSITION UTILE POUR LA PREPARATION D'UN OVULE

BIOCODEX [FR] · Granted Thu Nov 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

AU 2016249784

Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis

ASTELLAS PHARMA INC [JP] · Granted Thu Nov 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808532

Peptides whose uptake in cells is controllable

The Regents of the University of California · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808524

Combination of local and systemic immunomodulative therapies for melanoma and liver cancer

Provectus Pharmatech, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808525

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808520

Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808528

Protein-polymer-drug conjugates and methods of using same

Mersana Therapeutics, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808486

Administration of kynurenine depleting enzymes for tumor therapy

The Board of Regents of the University of Texas System · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808460

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808465

Emulsion formulations of aprepitant

Heron Therapeutics, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808475

Bovine milk oligosaccharides

The Regents of the University of California · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808458

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808448

Pharmaceutical compounds and use of same in cancer and tauopathies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808488

Isolated populations of renal stem cells and methods of isolating and using same

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808428

Compositions and methods for the delivery of therapeutics

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808424

Method for formulating large diameter synthetic membrane vesicles

Pacira Pharmaceuticals, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808407

Porous silica particle, method for producing the same, and cosmetic containing the same

JGC Catalysts and Chemicals Ltd. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808533

Multi-arm polymer prodrugs

Nektar Therapeutics · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809569

Process for producing heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808543

Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

The Board of Regents of the University of Texas System · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809539

Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

Shuttle Pharmaceuticals, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809541

LSD1 inhibitors

Mirati Therapeutics, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809588

GLS1 inhibitors for treating disease

The Board of Regents of the University of Texas System · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809604

DGAT1 inhibitor and preparation method and use thereof

Medshine Discovery Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809623

α4β7 peptide monomer and dimer antagonists

Protagonist Therapeutics, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809824

CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809649

Cachexia treatment

XBIOTECH INC. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808505

Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)

The Board of Regents of the University of Texas System · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808459

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9808510

Method for delivering gonadotropin releasing hormone into a lumen of the intestinal tract

Rani Therapeutics, LLC · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809814

Compositions and methods of nucleic acid-targeting nucleic acids

Caribou Biosciences, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9809643

Identification of antibodies specific for at least two different lyssaviruses

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3018619

COMPOSITION OPHTALMIQUE COMPRENANT UNE COMBINAISON SYNERGIQUE DE GLYCOGENE ET D'ACIDE HYALURONIQUE OU D'UN SEL DE CELUI-CI

ACRAF [IT] · Granted Thu Nov 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9814701

Compositions and methods for the treatment of macular degeneration

Aldeyra Therapeutics, Inc. · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9814422

Compositions for solubilizing cells and/or tissue

The Regents of the University of California · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9814706

Hydrobromide salt of pridopidine

TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9814755

Methods for the treatment of depression and anxiety

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9814789

Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma

Julius-Maximilians-Universitat Wurzburg · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9815796

Pyrimidone carboxamide compounds as PDE2 inhibitors

MSD R&D (China) Co. Ltd. · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)